Hepatology
From the Journals
HCV treatment program achieves 97% SVR among homeless
A community-based primary-care treatment program achieved a 97% sustained virologic response rate at 12 weeks among homeless adults with hepatitis...
News
FDA approves Sovaldi, Harvoni for HCV in ages 12-plus
The Food and Drug Administration has approved the use of Sovaldi (sofosbuvir) and Harvoni (ledipasvir and sofosbuvir) for the treatment of...
From the Journals
Hepatitis B, C appear to raise Parkinson’s risk
Hepatitis B and C appear to raise the risk of later Parkinson’s disease (PD), according to a report published in Neurology.The etiology of...
Guidelines
Eliminating hepatitis in the United States: A road map
A new report shows how deaths and new infections can be slashed, but some question whether the political will is there.
From the Journals
Elbasvir, grazoprevir beat HCV despite compensated cirrhosis
Twelve weeks of treatment produced SVR in both treatment-naive and treatment-experienced patients.
Conference Coverage
Doubt expressed about potential of any single regimen to treat all hep C
PHILADELPHIA – Individualized care and follow-up will still be needed to treat HCV.
Conference Coverage
Of six milestones, only two left on route to hep B cure
PHILADELPHIA – As in hepatitis C, it is likely a combination of therapies will be essential to achieve eradication of hep B and infection cure.
From the Journals
Childhood adiposity tied to NAFLD and elevated ALT in adulthood
Childhood obesity and overweight have implications for adult liver disease.
Conference Coverage
Three clinical disorders confound diagnosis of gastroparesis
A detailed history should be taken before advanced diagnostic tests are ordered.
Conference Coverage
Therapeutic window is narrow for steroids in alcoholic hepatitis
PHILADELPHIA – The main lesson for discordant data regarding the benefit of corticosteroids for alcoholic hepatitis is that mortality reductions...
Conference Coverage
Liver disease likely to become increasing indication for bariatric surgery
Bariatric surgery is effective for treatment of fatty liver disease, showing a 90% improvement in steatosis.